Current IQWiG guidelines do not provide an "appropriate foundation for informing German decision makers about the value of a health technology,"

Author：  

Publisher： Adis International

ISSN： 1173-5503

Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.573, 2009-01, pp. : 3-3

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Do Pharmacogenomic Tests Provide Value to Policy Makers?

By Ya-Chen Tina Shih  

PharmacoEconomics, Vol. 24, Iss. 12, 2006-01 ,pp. : 1173-1177

Adis International

Access to resources Recommend Favorite

Most decision-makers value economic evaluations

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 280, 2000-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Good Practice Guidelines for Decision-Analytic Modelling in Health Technology Assessment: A Review and Consolidation of Quality Assessment

By Philips Zoë   Bojke Laura  

PharmacoEconomics, Vol. 24, Iss. 4, 2006-01 ,pp. : 355-371

Adis International

Access to resources Recommend Favorite

The Value of Value of Information: Best Informing Research Design and Prioritization Using Current Methods

By Eckermann Simon  

PharmacoEconomics, Vol. 28, Iss. 9, 2010-09 ,pp. : 699-709

Adis International

Access to resources Recommend Favorite

Health economics and outcomes research: informing companion diagnostic development, guidelines, adoption and reimbursement

By Lee Jim   Lopez-Rios Fernando  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 5, 2013-06 ,pp. : 413-415

Informa Healthcare

Access to resources Recommend Favorite